Price:
Rs. 7,050.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: U0002
Frequently Asked Questions (FAQ's):
What does the UGT1A1 Gene Polymorphism test include at Metropolis Healthcare?
It includes targeted analysis of key UGT1A1 variants that influence bilirubin processing and drug metabolism.
How does Metropolis Healthcare perform this molecular test?
The test is conducted using validated molecular methods to precisely detect clinically significant polymorphisms.
Who should consider this test at Metropolis Healthcare?
Patients evaluated for unexplained jaundice, suspected Gilbert syndrome, or those starting certain chemotherapies may benefit from this test.
Why is this genetic test important at Metropolis Healthcare?
It helps predict drug sensitivity and bilirubin elevation risks, supporting safer and more personalized treatment planning.
Is any preparation required for this EDTA blood test at Metropolis Healthcare?
No special preparation is needed; a routine EDTA blood sample is sufficient.
How soon are results available from Metropolis Healthcare?
Results are typically provided within the standard turnaround time for genetic testing.
What do abnormal UGT1A1 findings mean in a Metropolis Healthcare report?
Detected variants may indicate reduced enzyme activity, which can affect bilirubin levels or drug tolerance.
Can this test be combined with other pharmacogenetic evaluations at Metropolis Healthcare?
Yes, it can be included in broader pharmacogenomic panels to optimize medication safety and efficacy